U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. WD Import and Export Inc. - 516144 - 02/13/2018
  1. Warning Letters

CLOSEOUT LETTER

WD Import and Export Inc. MARCS-CMS 516144 —


Recipient:
WD Import and Export Inc.

United States

Issuing Office:

United States


 

   

Black HHS-Blue FDA Logo

 

Office of Regulatory Affairs
Office of Enforcement and Import Operations
Division of Northeast Imports 

 
 

February 13, 2018

Mr. Chien Chen Wang, Owner
WD Import and Export, Inc.
4703 2nd Avenue
Brooklyn, NY 11232-4218

Dear Mr. Wang:

The Food & Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter NYK-2017-4, dated January 26, 2017. Based on our evaluation it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Slater K. Bartlett
Acting Compliance Officer
Division of Northeast Imports-Compliance Branch

Back to Top